Ethik-Board für Arzneimittelproduzenten
Crossref DOI link: https://doi.org/10.1007/s44180-024-00199-7
Published Online: 2024-08-29
Published Print: 2024-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Likar, Rudolf
Text and Data Mining valid from 2024-08-01
Version of Record valid from 2024-08-01
Article History
Accepted: 19 June 2024
First Online: 29 August 2024
Interessenkonflikt
: R. Likar gibt an, dass kein Interessenkonflikt besteht.
Free to read: This content has been made available to all.